Clin Exp Otorhinolaryngol.
2023 Nov;16(4):291-307. 10.21053/ceo.2023.00458.
Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force
- Korean Society of Laryngology, Phoniatrics, and Logopedics Guideline Task Force1
- Ban MJ
1 - Ryu CH2
- Woo JH3
- Lee YC4
- Lee DK5
- Kwon M6
- Hong YT7
- Lee GJ8
- Byeon HK9
- Choi SH6
- Lee SW10
- Affiliations
-
- 1Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
- 2Department of Otorhinolaryngology-Head and Neck Surgery, National Cancer Center, Goyang, Korea
- 3Department of Otorhinolaryngology-Head and Neck Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- 4Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Korea
- 5Department of Otorhinolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
- 6Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 7Department of Otorhinolaryngology-Head and Neck Surgery, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea
- 8Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Kyungpook National University, Daegu, Korea
- 9Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
- 10Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
- KMID: 2548358
- DOI: http://doi.org/10.21053/ceo.2023.00458
Abstract
- The Korean Society of Laryngology, Phoniatrics and Logopedics created a task force to establish clinical practice guidelines for the use of botulinum toxin (BT) in otolaryngology. We selected 10 disease categories: spasmodic dysphonia, essential vocal tremor, vocal fold granuloma, bilateral vocal fold paralysis, Frey’s syndrome, sialocele, sialorrhea, cricopharyngeal dysfunction, chronic sialadenitis, and first bite syndrome. To retrieve all relevant papers, we searched the CORE databases with predefined search strategies, including Medline (PubMed), Embase, the Cochrane Library, and KoreaMed. The committee reported 13 final recommendations with detailed evidence profiles. The guidelines are primarily aimed at all clinicians applying BT to the head and neck area. In addition, the guidelines aim to promote an improved understanding of the safe and effective use of BT by policymakers and counselors, as well as in patients scheduled to receive BT injections.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Erratum: Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force
- Clinical Application of Botulinum Toxin to Contact Granuloma and Vocal Nodule
- Practical Issue of Botulinum Toxin use Liquid Type, Storage and Reuse
- Clinical Application of Botulinum Toxin to Functional Dysphonia
- Dysphagia after Retropharyngeal Abscess Treated with Transcutaneous Injection of Botulinum Toxin at Cricopharyngeus Muscle
